4.6 Article

Mediator lipidomics by liquid chromatography-tandem mass spectrometry

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbalip.2017.03.008

Keywords

Mass spectrometer; Quantification; Eicosanoids; Cross-platform

Funding

  1. Ono Pharmaceutical Co., Ltd.
  2. Shimadzu, Corp.
  3. Ministry of Education, Culture, Sports, Science and Technology, Japan [24229003, 15K08296]
  4. Grants-in-Aid for Scientific Research [15K08296] Funding Source: KAKEN

Ask authors/readers for more resources

Comprehensive quantitative analysis of lipid mediators using liquid chromatography-tandem mass spectrometry is an effective strategy in the elucidation of disease mechanisms; but technically, it has been and is still a great challenge to achieve reliable datasets that cover variety of lipid metabolites contained at trace levels in complex biological matrices. In this opinion article, we introduce our experiences in developing lipid mediator profiling systems, and deliver some comments on limitations of current methodology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available